- Home
- PTON vs APLS Comparison
PTON vs APLS Comparison
Compare PTON & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTON
- APLS
- Stock Information
- Founded
- PTON 2012
- APLS 2009
- Country
- PTON United States
- APLS United States
- Employees
- PTON N/A
- APLS N/A
- Industry
- PTON Recreational Games/Products/Toys
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- PTON Consumer Discretionary
- APLS Health Care
- Exchange
- PTON Nasdaq
- APLS Nasdaq
- Market Cap
- PTON 3.2B
- APLS 3.5B
- IPO Year
- PTON 2019
- APLS 2017
- Fundamental
- Price
- PTON $7.41
- APLS $24.92
- Analyst Decision
- PTON Buy
- APLS Buy
- Analyst Count
- PTON 15
- APLS 20
- Target Price
- PTON $9.13
- APLS $33.47
- AVG Volume (30 Days)
- PTON 14.7M
- APLS 2.2M
- Earning Date
- PTON 10-30-2025
- APLS 11-04-2025
- Dividend Yield
- PTON N/A
- APLS N/A
- EPS Growth
- PTON N/A
- APLS N/A
- EPS
- PTON N/A
- APLS N/A
- Revenue
- PTON $2,490,800,000.00
- APLS $754,649,000.00
- Revenue This Year
- PTON $0.05
- APLS $22.11
- Revenue Next Year
- PTON $1.69
- APLS N/A
- P/E Ratio
- PTON N/A
- APLS N/A
- Revenue Growth
- PTON N/A
- APLS 20.02
- 52 Week Low
- PTON $4.52
- APLS $16.10
- 52 Week High
- PTON $10.90
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- PTON 38.44
- APLS 57.14
- Support Level
- PTON $8.10
- APLS $21.07
- Resistance Level
- PTON $9.20
- APLS $23.50
- Average True Range (ATR)
- PTON 0.59
- APLS 0.78
- MACD
- PTON -0.09
- APLS 0.18
- Stochastic Oscillator
- PTON 3.17
- APLS 99.10
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.